As of Dec 15
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Bio Path Holdings Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +581.82% increase from the last price of 0.22.
The current consensus among 1 polled investment analysts is to Buy stock in Bio Path Holdings Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.